Cargando…

Prevalence of healthy aging among community dwelling adults age 70 and older from five European countries

BACKGROUND: To compare the prevalence of healthy aging among adults age 70 and older from 5 European countries recruited for the DO-HEALTH clinical trial. Participants were selected for absence of prior major health events. METHODS: Cross-sectional analysis of DO-HEALTH baseline data. All 2,157 part...

Descripción completa

Detalles Bibliográficos
Autores principales: Schietzel, Simeon, Chocano-Bedoya, Patricia O., Sadlon, Angelique, Gagesch, Michael, Willett, Walter C., Orav, Endel J., Kressig, Reto W., Vellas, Bruno, Rizzoli, René, da Silva, José A. P., Blauth, Michael, Kanis, John A., Egli, Andreas, Bischoff-Ferrari, Heike A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889763/
https://www.ncbi.nlm.nih.gov/pubmed/35236290
http://dx.doi.org/10.1186/s12877-022-02755-8
_version_ 1784661475408740352
author Schietzel, Simeon
Chocano-Bedoya, Patricia O.
Sadlon, Angelique
Gagesch, Michael
Willett, Walter C.
Orav, Endel J.
Kressig, Reto W.
Vellas, Bruno
Rizzoli, René
da Silva, José A. P.
Blauth, Michael
Kanis, John A.
Egli, Andreas
Bischoff-Ferrari, Heike A.
author_facet Schietzel, Simeon
Chocano-Bedoya, Patricia O.
Sadlon, Angelique
Gagesch, Michael
Willett, Walter C.
Orav, Endel J.
Kressig, Reto W.
Vellas, Bruno
Rizzoli, René
da Silva, José A. P.
Blauth, Michael
Kanis, John A.
Egli, Andreas
Bischoff-Ferrari, Heike A.
author_sort Schietzel, Simeon
collection PubMed
description BACKGROUND: To compare the prevalence of healthy aging among adults age 70 and older from 5 European countries recruited for the DO-HEALTH clinical trial. Participants were selected for absence of prior major health events. METHODS: Cross-sectional analysis of DO-HEALTH baseline data. All 2,157 participants (mean age 74.9, SD 4.4; 61.7% women) were included and 2,123 had data for all domains of the healthy aging status (HA) definition. HA was assessed based on the Nurses` Health Study (NHS) definition requiring four domains: no major chronic diseases, no disabilities, no cognitive impairment (Montreal Cognitive Assessment, MoCA ≥25), no mental health limitation (GDS-5 <2, and no diagnosis of depression). Association between HA and age, BMI, gender, and physical function (sit-to-stand, gait speed, grip strength) was assessed by multivariate logistic regression analyses adjusting for center. RESULTS: Overall, 41.8% of DO-HEALTH participants were healthy agers with significant variability by country: Austria (Innsbruck) 58.3%, Switzerland (Zurich, Basel, Geneva) 51.2%, Germany (Berlin) 37.6%, France (Toulouse) 36.7% and Portugal (Coimbra) 8.8% (p <0.0001). Differences in prevalence by country persisted after adjustment for age. In the multivariate model, younger age (OR = 0.95, 95% CI 0.93 to 0.98), female gender (OR = 1.36, 95% CI 1.03 to 1.81), lower BMI (OR = 0.94, 95% CI 0.91 to 0.96), faster gait speed (OR = 4.70, 95% CI 2.68 to 8.25) and faster performance in sit-to-stand test (OR = 0.90, 95% CI 0.87 to 0.93) were independently and significantly associated with HA. CONCLUSIONS: Despite the same inclusion and exclusion criteria preselecting relatively healthy adults age 70 years and older, HA prevalence in DO-HEALTH varied significantly between countries and was highest in participants from Austria and Switzerland, lowest in participants from Portugal. Independent of country, younger age, female gender, lower BMI and better physical function were associated with HA. TRIAL REGISTRATION: DO-HEALTH was registered under the protocol NCT01745263 at the International Trials Registry (clinicaltrials.gov), and under the protocol number 2012–001249-41 at the Registration at the European Community Clinical Trial System (EudraCT). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12877-022-02755-8.
format Online
Article
Text
id pubmed-8889763
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-88897632022-03-09 Prevalence of healthy aging among community dwelling adults age 70 and older from five European countries Schietzel, Simeon Chocano-Bedoya, Patricia O. Sadlon, Angelique Gagesch, Michael Willett, Walter C. Orav, Endel J. Kressig, Reto W. Vellas, Bruno Rizzoli, René da Silva, José A. P. Blauth, Michael Kanis, John A. Egli, Andreas Bischoff-Ferrari, Heike A. BMC Geriatr Research BACKGROUND: To compare the prevalence of healthy aging among adults age 70 and older from 5 European countries recruited for the DO-HEALTH clinical trial. Participants were selected for absence of prior major health events. METHODS: Cross-sectional analysis of DO-HEALTH baseline data. All 2,157 participants (mean age 74.9, SD 4.4; 61.7% women) were included and 2,123 had data for all domains of the healthy aging status (HA) definition. HA was assessed based on the Nurses` Health Study (NHS) definition requiring four domains: no major chronic diseases, no disabilities, no cognitive impairment (Montreal Cognitive Assessment, MoCA ≥25), no mental health limitation (GDS-5 <2, and no diagnosis of depression). Association between HA and age, BMI, gender, and physical function (sit-to-stand, gait speed, grip strength) was assessed by multivariate logistic regression analyses adjusting for center. RESULTS: Overall, 41.8% of DO-HEALTH participants were healthy agers with significant variability by country: Austria (Innsbruck) 58.3%, Switzerland (Zurich, Basel, Geneva) 51.2%, Germany (Berlin) 37.6%, France (Toulouse) 36.7% and Portugal (Coimbra) 8.8% (p <0.0001). Differences in prevalence by country persisted after adjustment for age. In the multivariate model, younger age (OR = 0.95, 95% CI 0.93 to 0.98), female gender (OR = 1.36, 95% CI 1.03 to 1.81), lower BMI (OR = 0.94, 95% CI 0.91 to 0.96), faster gait speed (OR = 4.70, 95% CI 2.68 to 8.25) and faster performance in sit-to-stand test (OR = 0.90, 95% CI 0.87 to 0.93) were independently and significantly associated with HA. CONCLUSIONS: Despite the same inclusion and exclusion criteria preselecting relatively healthy adults age 70 years and older, HA prevalence in DO-HEALTH varied significantly between countries and was highest in participants from Austria and Switzerland, lowest in participants from Portugal. Independent of country, younger age, female gender, lower BMI and better physical function were associated with HA. TRIAL REGISTRATION: DO-HEALTH was registered under the protocol NCT01745263 at the International Trials Registry (clinicaltrials.gov), and under the protocol number 2012–001249-41 at the Registration at the European Community Clinical Trial System (EudraCT). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12877-022-02755-8. BioMed Central 2022-03-02 /pmc/articles/PMC8889763/ /pubmed/35236290 http://dx.doi.org/10.1186/s12877-022-02755-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Schietzel, Simeon
Chocano-Bedoya, Patricia O.
Sadlon, Angelique
Gagesch, Michael
Willett, Walter C.
Orav, Endel J.
Kressig, Reto W.
Vellas, Bruno
Rizzoli, René
da Silva, José A. P.
Blauth, Michael
Kanis, John A.
Egli, Andreas
Bischoff-Ferrari, Heike A.
Prevalence of healthy aging among community dwelling adults age 70 and older from five European countries
title Prevalence of healthy aging among community dwelling adults age 70 and older from five European countries
title_full Prevalence of healthy aging among community dwelling adults age 70 and older from five European countries
title_fullStr Prevalence of healthy aging among community dwelling adults age 70 and older from five European countries
title_full_unstemmed Prevalence of healthy aging among community dwelling adults age 70 and older from five European countries
title_short Prevalence of healthy aging among community dwelling adults age 70 and older from five European countries
title_sort prevalence of healthy aging among community dwelling adults age 70 and older from five european countries
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889763/
https://www.ncbi.nlm.nih.gov/pubmed/35236290
http://dx.doi.org/10.1186/s12877-022-02755-8
work_keys_str_mv AT schietzelsimeon prevalenceofhealthyagingamongcommunitydwellingadultsage70andolderfromfiveeuropeancountries
AT chocanobedoyapatriciao prevalenceofhealthyagingamongcommunitydwellingadultsage70andolderfromfiveeuropeancountries
AT sadlonangelique prevalenceofhealthyagingamongcommunitydwellingadultsage70andolderfromfiveeuropeancountries
AT gageschmichael prevalenceofhealthyagingamongcommunitydwellingadultsage70andolderfromfiveeuropeancountries
AT willettwalterc prevalenceofhealthyagingamongcommunitydwellingadultsage70andolderfromfiveeuropeancountries
AT oravendelj prevalenceofhealthyagingamongcommunitydwellingadultsage70andolderfromfiveeuropeancountries
AT kressigretow prevalenceofhealthyagingamongcommunitydwellingadultsage70andolderfromfiveeuropeancountries
AT vellasbruno prevalenceofhealthyagingamongcommunitydwellingadultsage70andolderfromfiveeuropeancountries
AT rizzolirene prevalenceofhealthyagingamongcommunitydwellingadultsage70andolderfromfiveeuropeancountries
AT dasilvajoseap prevalenceofhealthyagingamongcommunitydwellingadultsage70andolderfromfiveeuropeancountries
AT blauthmichael prevalenceofhealthyagingamongcommunitydwellingadultsage70andolderfromfiveeuropeancountries
AT kanisjohna prevalenceofhealthyagingamongcommunitydwellingadultsage70andolderfromfiveeuropeancountries
AT egliandreas prevalenceofhealthyagingamongcommunitydwellingadultsage70andolderfromfiveeuropeancountries
AT bischoffferrariheikea prevalenceofhealthyagingamongcommunitydwellingadultsage70andolderfromfiveeuropeancountries